Aardvark Share Price

Aardvark Share Price

NASDAQ: AARD | Micro Cap | Healthcare
$1.01
-$0.17 (-13.98%) Last updated on 19 Nov, 2026 | 00:45 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Aardvark Stock Performance

Open
$1.12
Prev. Close
$1.18
Circuit Range
N/A
Day Range
$1.01 - $1.12
Year Range
$0.94 - $16.41
Volume
3,411
Average Traded
$1.06

Aardvark Share Price Today

As of 19 November 2026, Aardvark Therapeutics, Inc.'s share price is $1.01. The stock opened at $1.12, compared to its previous close of $1.18. During today's trading session, Aardvark Therapeutics, Inc.'s share price traded between $1.01 and $1.12, with an average price of $1.06. Over the past 52 weeks, the stock has recorded a high of $16.41 and a low of $0.94. In terms of performance, Aardvark Therapeutics, Inc.'s share price has declined by 75.30% over the last six months and is down 89.81% on a year-on-year basis.

Aardvark Share Price Chart

Line chart of the Aardvark price trend over the selected period. The price fell overall, ranging from 1.01 to 1.12, ending at 1.01.
$1.01$1.12
L
Show Current Price
H

Aardvark Stock Fundamentals & Key Indicators

Market Cap
$19.92M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.32
Revenue (TTM)
$0.00
Return On Equity (TTM)
-126.30%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-9.03%

Aardvark Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$17.60-$21.59-$14.39-$19.19
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-22.67%33.35%-33.36%

Aardvark Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$0.00
Net Profit-$57.59
Net Profit MarginN/A
Income ChangeN/A

Aardvark Balance Sheet

All figures in USD Million

Particulars2025
Non Current Assets5.3
Current Assets111.89
Total Assets117.18
Non Current Liabilities0.0
Current Liabilities10.55
Total Liabilities10.55
Shareholders' Equity106.63

Aardvark Cash Flow

Annually

All figures in USD Million

Particulars2025
Operating-54.17
Investing-49.67
Financing89.25

About Aardvark

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.

Aardvark Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.36
$1.01
-26.28%
Oct 2026
$5.23
$1.37
-74.08%
Sep 2026
$6.22
$5.29
-20.53%
Aug 2026
$6.74
$6.65
+2.62%
Jul 2026
$5.76
$6.48
+12.60%
Jun 2026
$3.98
$5.75
+40.02%
May 2026
$5.17
$4.11
-24.10%
Apr 2026
$3.87
$5.42
+44.40%
Mar 2026
$5.72
$3.75
-70.20%
Feb 2026
$12.80
$12.59
-2.97%
Jan 2026
$12.60
$12.97
-0.92%
Dec 2025
$9.95
$13.09
+31.43%

Aardvark Share Price FAQs